Markets

DENTSPLY's (XRAY) Q4 Earnings In Line; Revenues lag

DENTSPLY International Inc XRAY is one of the leading worldwide manufacturers' dental consumables, dental laboratory products, dental specialty products and consumable medical device products. The company has global operations with sales in more than 120 countries.

Currently, this York, PA- based company carries a Zacks Rank #3 (Hold) but that could change following its fourth quarter 2015 earnings report which has just released. We have highlighted some of the key details from the just-released announcement below:

Earnings : The Zacks Consensus Estimate remained steady at 65 cents per share over the last 30 days. DENTSPLY's adjusted earnings of 65 cents per share were in line with this estimate and increased 3.3% on a year-over-year basis.

Revenues : DENTSPLY's net sales declined 6.5% year over year to $645.9 million, also missing the Zacks Consensus Estimate of $689 million.

Key Stats : Adjusted operating margin expanded nearly 220 basis points (bps) on a year -over -year basis to 19.9%, primarily on the back of DENTSPLY's global efficiency program.

Major Factors : Management expects the merger with Sirona Dental to be completed in the first quarter of 2016.

Stock Price : Following the earnings release, share prices did not show any movement in the pre-market trading session.

Check back later for our full write up on this DENTSPLY earnings report later!

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

DENTSPLY INTL (XRAY): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

XRAY

Other Topics

Earnings Investing Stocks

Latest Markets Videos